APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 17 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,645,338 | +36.2% | 12,454 | +159.7% | 0.18% | +19.6% |
| Q2 2023 | $11,487,633 | -6.5% | 4,796 | -99.9% | 0.15% | +3.4% |
| Q1 2022 | $12,281,000 | +41.1% | 7,728,000 | +34.7% | 0.15% | +134.9% |
| Q4 2021 | $8,705,000 | +62.7% | 5,739,000 | +33.2% | 0.06% | +37.0% |
| Q3 2021 | $5,350,000 | -22.1% | 4,310,000 | +16.2% | 0.05% | -25.8% |
| Q2 2021 | $6,866,000 | +270.9% | 3,709,000 | +115.1% | 0.06% | +67.6% |
| Q3 2020 | $1,851,000 | – | 1,724,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
| LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
| Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 504,000 | $623,398 | 0.00% |